Big Pharma, Biotech Attack NASH Liver Illness From All Sides 31 minutes ago


It's been called a "silent epidemic" that's slowly wasting away the livers of millions of Americans while doctors have a paltry understanding of the disease and no approved treatments. Non-alcoholic steatohepatitis, or NASH, is now in the sights of more than a dozen drugmakers.



from Biotech News